Bioactive acylphloroglucinol derivatives from Eucalyptus species.
The acyphloroglucinol derivatives produced by Eucalyptus species are reviewed. Aspects of their chemistry, stereochemistry, biological activity and biogenesis are discussed.
Ghisalberti
E L
EL
Department of Chemistry, University of Western Australia, Australia.
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents / Q000737:chemistry* / Q000494:pharmacology*; D003930:Diabetic Retinopathy / Q000201:enzymology; D005052:Eucalyptus; D005658:Fungi / Q000187:drug effects; D006090:Gram-Negative Bacteria / Q000187:drug effects; D006094:Gram-Positive Bacteria / Q000187:drug effects*; D006678:HIV / Q000201:enzymology; D006801:Humans; D008826:Microbial Sensitivity Tests; D015394:Molecular Structure; D010696:Phloroglucinol / Q000031:analogs & derivatives* / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D010946:Plants, Medicinal; D018894:Reverse Transcriptase Inhibitors / Q000737:chemistry / Q000494:pharmacology; D013045:Species Specificity; D014961:X-Ray Diffraction
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D018894:Reverse Transcriptase Inhibitors; D010696:Phloroglucinol; D000449:Aldehyde Reductase